• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于肥大细胞脱颗粒(MCD)肽介导组胺释放的结构要求的进一步研究。

Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release.

作者信息

Buku A, Price J A

机构信息

Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York, NY 10029, USA.

出版信息

Peptides. 2001 Dec;22(12):1987-91. doi: 10.1016/s0196-9781(01)00538-1.

DOI:10.1016/s0196-9781(01)00538-1
PMID:11786181
Abstract

Mast cell degranulating (MCD) peptide was modified in its two disulfide bridges and in the two arginine residues in order to measure the ability of these analogs to induce histamine release from mast cells in vitro. Analogs prepared were [Ala(3,15)]MCD, [Ala(5,19)]MCD, [Orn(16)]MCD, and [Orn(7,16)]MCD. Their histamine-releasing activity was determined spectrofluorometrically with peritoneal mast cells. The monocyclic analogs in which the cysteine residues were replaced pairwise with alanine residues showed three-to ten-fold diminished histamine-releasing activity respectively, compared with the parent MCD peptide. Substantial increases in activity were observed where arginine residues were replaced by ornithines. The ornithine-mono substituted analog showed an almost six-fold increase and the ornithine-doubly substituted analog three-fold increase in histamine-releasing activity compared with the parent MCD peptide. The structural changes associated with these activities were followed by circular dichroism (CD) spectroscopy. Changes in the shape and ellipticity of the CD spectra reflected a role for the disulfide bonds and the two arginine residues in the overall conformation and biological activity of the molecule.

摘要

为了测定这些类似物在体外诱导肥大细胞释放组胺的能力,对肥大细胞脱颗粒(MCD)肽的两个二硫键和两个精氨酸残基进行了修饰。制备的类似物有[Ala(3,15)]MCD、[Ala(5,19)]MCD、[Orn(16)]MCD和[Orn(7,16)]MCD。用腹膜肥大细胞通过荧光分光光度法测定了它们的组胺释放活性。与母体MCD肽相比,半胱氨酸残基被丙氨酸残基成对取代的单环类似物的组胺释放活性分别降低了三至十倍。当精氨酸残基被鸟氨酸取代时,观察到活性大幅增加。与母体MCD肽相比,鸟氨酸单取代类似物的组胺释放活性增加了近六倍,鸟氨酸双取代类似物增加了三倍。通过圆二色性(CD)光谱跟踪与这些活性相关的结构变化。CD光谱形状和椭圆率的变化反映了二硫键和两个精氨酸残基在分子整体构象和生物活性中的作用。

相似文献

1
Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release.关于肥大细胞脱颗粒(MCD)肽介导组胺释放的结构要求的进一步研究。
Peptides. 2001 Dec;22(12):1987-91. doi: 10.1016/s0196-9781(01)00538-1.
2
Mast cell degranulating (MCD) peptide analogs with reduced ring structure.
J Protein Chem. 1992 Jun;11(3):275-80. doi: 10.1007/BF01024866.
3
Partial alanine scan of mast cell degranulating peptide (MCD): importance of the histidine- and arginine residues.
J Pept Sci. 2004 Jun;10(6):313-7. doi: 10.1002/psc.532.
4
Bioactivities and secondary structure of mast cell degranulating (MCD) peptide analogs.
Peptides. 1998;19(1):1-5. doi: 10.1016/s0196-9781(97)00253-2.
5
Histamine-releasing activity and binding to the FcepsilonRI alpha human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions.组胺释放活性以及与具有丙氨酸取代的肥大细胞脱颗粒肽类似物的FcepsilonRIα人肥大细胞受体亚基的结合。
J Med Chem. 2003 Jul 3;46(14):3008-12. doi: 10.1021/jm0204892.
6
Circular dichroism (CD) studies on biological activity of mast cell degranulating (MCD) peptide analogs.
Int J Pept Protein Res. 1994 Nov;44(5):410-3. doi: 10.1111/j.1399-3011.1994.tb00175.x.
7
Effective mast cell degranulating peptide inhibitors of the IgE/Fc epsilonRI receptor interaction.有效的IgE/FcεRI受体相互作用的肥大细胞脱颗粒肽抑制剂。
Chem Biol Drug Des. 2008 Aug;72(2):133-9. doi: 10.1111/j.1747-0285.2008.00684.x. Epub 2008 Jul 10.
8
[Ala12]MCD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors.[丙氨酸12]MCD肽:一种导向免疫球蛋白E与肥大细胞受体结合抑制剂的先导肽。
J Pept Res. 2005 Sep;66(3):132-7. doi: 10.1111/j.1399-3011.2005.00281.x.
9
Solid phase synthesis and biological activity of mast cell degranulating (MCD) peptide: a component of bee venom.
Int J Pept Protein Res. 1989 Feb;33(2):86-93. doi: 10.1111/j.1399-3011.1989.tb00192.x.
10
Mast cell degranulating (MCD) peptide: a prototypic peptide in allergy and inflammation.肥大细胞脱颗粒(MCD)肽:过敏和炎症中的一种原型肽。
Peptides. 1999;20(3):415-20. doi: 10.1016/s0196-9781(98)00167-3.

引用本文的文献

1
Bee Venom: An Updating Review of Its Bioactive Molecules and Its Health Applications.蜂毒:生物活性分子及其健康应用的最新综述。
Nutrients. 2020 Oct 31;12(11):3360. doi: 10.3390/nu12113360.
2
Immunology of Bee Venom.蜂毒的免疫学。
Clin Rev Allergy Immunol. 2018 Jun;54(3):386-396. doi: 10.1007/s12016-017-8597-4.